1Blanchard JW, Grotenhuis I, LaFave JW, et al. Blood supply to hepatic VX- 2 Carcinoma implants as measured by radioactive microspheres. Proc. Soc. Exp. Biol. Med, 1965, 118: 465～468.
2Zlotecki R, Gyves J, Ensminger W, et al. Epinephrine induces shunting of blood flow to rabbit hepatic VX - 2 implants.American Association for Cancer Research Proceedings (abstr.),1985, 26: 1392.
3Munck JN, Riggi M, Rougier, et al. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraaterial hepatic administration in the rabbit VX 2 tumor model. Cancer Res, 1993, 53: 1550-1554.
4Hayashi Y, Fukushima S, Kishimoto S, et al. Anticancer effects of the polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX -2 tumor. Cancer Res,1992, 52: 400-405.
5Gordon IL, Kar r, Opfel RW, et al. Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits. Cancer Res, 1987, 47: 5070- 5073.
6Fukushima S, kawaguchi T, Nishida M, et al. Selective anticancer effects of 3′, 5′ - dioctanol - 5 - fluoro - 2′ deoxyuridine, a lipophilic prodrug of 5 - fluoro - 2′ - deoxyuridine, dissolved in a oily lymphographic agent on hepatic cancer of rabbits bearing VX - 2tumor. Cancer Res, 1987, 47: 1930-1934.
7Pauser S, Wanger S, Lippmann M, et al. Evaluation of effcient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: An experimental study on the VX 2 tumor in the rabbit liver. Cancer Res, 1996, 56: 1863- 1867.
8Smith WE, Kidd JG, Rous P, et al. Experiments of the cause of the rabbit carcinomas derived from virus - induced papillomas.I. Propagation of several of the cancers in sucklings, with etiological tests. J Exp Med, 1952, 95: 299-317.
9Rous P, Kidd JG, Smith WE, et al. Experiments of the cause of the rabbit carcinoma of the power to immunize hosts against the papilloma virus. J Exp Med, 1952, 96: 159- 174.
10Hough A, Seyberth H, Oates J, et al. Change in bone marrow of rabbits bearing the VX - 2 carcinoma. Am J Pathol, 1977,87: 537 - 547.
8Okada M,Kudo S,Miyazaki O,et al.Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intraarterial injetion in the rabbit VX2 tumor mode.Br J Cancer,1995,71:518-524.
9Munck JN,Kiggi M,Rougier P,et al.Pharmacokinetic and pharmacodnamic advantanges of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.Cancer Res,1993,53:1550-1554.
10Ramirez LH,Orlowski S,An S,et al.Electrochemotherapy on liver tumors in rabbits.Br J Cancer,1998,77:2104-2111.
